There was no significant difference in TFEB or ERRα expression among EC patients with different International Federation International of Gynecology and Obstetrics (FIGO) stages, histologic tumor grades, pathological types or lymph node metastasis (LNM) conditions (p > 0.05; Fig. 6C). The gene discussed is ESRRA; the disease is metastatic malignant neoplasm in the lymph nodes.